Shares of GSK PLC GSK slid 2.42% to £14.34 Wednesday, on what proved to be an all-around dismal trading session for the stock ...
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in ...
Shares of GSK plc (LON:GSK – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. One research ...
Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...
Explore more
1d
Zacks Investment Research on MSNWhy GSK (GSK) is a Top Value Stock for the Long-TermIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 12.58%, which has investors questioning if this is right time to buy.
Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results